BGX 📈 Blackstone GSO Long Short - Overview

Exchange: NYSE • Country: USA • Currency: USD • Type: Fund • ISIN: US09257D1028 • Bank Loan

BGX: Corporate Bonds, Loans, High Yield Bonds, Equities

Additional Sources for BGX Fund

BGX Fund Overview

Market Cap in USD 170m
Style Bank Loan
TER 2.19%
IPO / Inception 2011-01-27

BGX Fund Ratings

Growth 5y 43.7%
Fundamental -
Dividend 69.8%
Rel. Strength Industry 409
Analysts -
Fair Price Momentum 13.44 USD
Fair Price DCF -

BGX Dividends

Dividend Yield 12m 8.94%
Yield on Cost 5y 11.49%
Annual Growth 5y -1.73%
Payout Consistency 92.7%

BGX Growth Ratios

Growth Correlation 3m 73.4%
Growth Correlation 12m 97%
Growth Correlation 5y 56.1%
CAGR 5y 5.15%
CAGR/Mean DD 5y 0.46
Sharpe Ratio 12m 1.75
Alpha 5.06
Beta 0.56
Volatility 11.50%
Current Volume 49.2k
Average Volume 20d 62.7k
What is the price of BGX stocks?
As of December 26, 2024, the stock is trading at USD 12.74 with a total of 49,166 shares traded.
Over the past week, the price has changed by +0.99%, over one month by +0.44%, over three months by +0.49% and over the past year by +22.75%.
Is Blackstone GSO Long Short a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Blackstone GSO Long Short (NYSE:BGX) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 43.74 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BGX as of December 2024 is 13.44. This means that BGX is currently overvalued and has a potential downside of 5.49%.
Is BGX a buy, sell or hold?
Blackstone GSO Long Short has no consensus analysts rating.
What are the forecast for BGX stock price target?
According to ValueRays Forecast Model, BGX Blackstone GSO Long Short will be worth about 14.7 in December 2025. The stock is currently trading at 12.74. This means that the stock has a potential upside of +15.62%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 14.7 15.6%